Juneyao Health 2026 Interim Report: Revenue Up 9.43%, Net Profit Down 39.74%

蓝鲸财经··CN·Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Juneyao Health released its 2026 interim report on August 26. During the reporting period, the company achieved operating revenue of 839 million yuan, up 9.43% year on year, but net profit attributable to the parent company was 45 million yuan, down 39.74% year on year, and non-GAAP net profit was 14 million yuan, down 18.05% year on year. Total profit surged 274.32% year on year, mainly thanks to improved operations at the controlling subsidiary Doctor Daily, but because of the parent company's shareholding ratio, this was not fully converted into net profit attributable to shareholders. Net cash flow from operating activities was negative 109 million yuan, with the net outflow slightly narrower than the same period last year. The decline in performance was mainly due to falling profits in the traditional ambient lactic acid bacteria business, as well as e-commerce investment that drove selling expenses up 38.95% year on year to 224 million yuan, while financial expenses rose sharply by 466.13% due to increased foreign exchange losses. The company is transforming from a traditional food and beverage manufacturer into a health science enterprise. Probiotic beverages, probiotic foods, and other beverages together contributed about 648 million yuan in main business revenue, of which probiotic food revenue was 182 million yuan and commodity supply chain business revenue was 186 million yuan.

Impact on assets 1

Others▼
JuneYao Dairy Co Ltd
605388
▼ NegativeCapitalrelevance

Interim report shows net profit down 39.74% and non-GAAP profit down 18.05%, with falling traditional lactic acid bacteria profits and surging selling/financial expenses.

Off-coverage companies 1

每日博士i
Private▲ PositiveCapitalrelevance

Improved operations at controlling subsidiary Doctor Daily drove total profit up 274.32%, though parent's shareholding ratio limited conversion to net profit.